XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Net Unrealized (Losses) Gains on Investments [Member]
Foreign Currency Translation (Losses) Gains [Member]
Nonredeemable Noncontrolling Interests [Member]
Balance at Dec. 31, 2022 $ 81,450 $ 9 $ 0 $ 86,156 $ (2,778) $ (5,615) $ 3,678
Balance (in shares) at Dec. 31, 2022   934          
Net earnings attributable to UnitedHealth Group common shareholders 5,611     5,611      
Net earnings attributable to nonredeemable noncontrolling interest             113
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 5,724            
Other comprehensive income (loss) 844       503 341  
Issuances of common stock, and related tax effects (in shares)   2          
Issuances of common stock, and related tax effects 350 $ 0 350        
Share-based compensation 366   366        
Common share repurchases (in shares)   (4)          
Common share repurchases (2,011) $ 0 (633) (1,378)      
Cash dividends paid on common shares (1,537)     (1,537)      
Redeemable noncontrolling interests fair value and other adjustments (83)   (83)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 819           819
Distribution to nonredeemable noncontrolling interests (101)           (101)
Balance at Mar. 31, 2023 $ 85,821 $ 9 0 88,852 (2,275) (5,274) 4,509
Balance (in shares) at Mar. 31, 2023   932          
Common Stock, Dividends, Per Share, Cash Paid $ 1.65            
Balance at Dec. 31, 2023 $ 94,421 $ 9 0 95,774 (1,971) (5,056) 5,665
Balance (in shares) at Dec. 31, 2023 924 924          
Net earnings attributable to UnitedHealth Group common shareholders $ (1,409)     (1,409)      
Net earnings attributable to nonredeemable noncontrolling interest             149
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest (1,260)            
Other comprehensive income (loss) 3,588       (247) 3,835  
Issuances of common stock, and related tax effects (in shares)   2          
Issuances of common stock, and related tax effects 242 $ 0 242        
Share-based compensation 352   352        
Common share repurchases (in shares)   (6)          
Common share repurchases (3,092) $ 0 (574) (2,518)      
Cash dividends paid on common shares (1,729)     (1,729)      
Redeemable noncontrolling interests fair value and other adjustments (20)   (20)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 19           19
Distribution to nonredeemable noncontrolling interests (151)           (151)
Balance at Mar. 31, 2024 $ 92,370 $ 9 $ 0 $ 90,118 $ (2,218) $ (1,221) $ 5,682
Balance (in shares) at Mar. 31, 2024 920 920          
Common Stock, Dividends, Per Share, Cash Paid $ 1.88